Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nausea and vomiting of pregnancy. Evidence-based treatment algorithm.

Literature DB >> 11889884

Nausea and vomiting of pregnancy. Evidence-based treatment algorithm.

Zina Levichek¹, Gardana Atanackovic, Dick Oepkes, Carolyn Maltepe, Adrienne Einarson, Laura Magee, Gideon Koren.

Abstract

QUESTION: One of my patients suffers from a moderate-to-severe form of morning sickness. She responded only partially to doxylamine and pyridoxine (Dicletin), and I wish to try adding another medication. What should my priority be? ANSWER: An algorithm used by Motherisk to manage thousands of patients takes a hierarchical approach to this condition. This approach is evidence based with regard to fetal safety as well as efficacy.

Entities: Chemical Disease Species

Mesh：

Substances：
Antiemetics

Year: 2002 PMID： 11889884 PMCID： PMC2213975

Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275

7 in total

1. Therapeutic abortions due to severe morning sickness. Unacceptable combination.

Authors: P Mazzota; L Magee; G Koren
Journal: Can Fam Physician Date: 1997-06 Impact factor: 3.275

Review 2. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors: P Mazzotta; L A Magee
Journal: Drugs Date: 2000-04 Impact factor: 9.546

3. A prospective study of nausea and vomiting during pregnancy.

Authors: R Gadsby; A M Barnie-Adshead; C Jagger
Journal: Br J Gen Pract Date: 1993-06 Impact factor: 5.386

4. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.

Authors: G Atanackovic; Y Navioz; M E Moretti; G Koren
Journal: J Clin Pharmacol Date: 2001-08 Impact factor: 3.126

5. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy.

Authors: P Mazzotta; D Stewart; G Atanackovic; G Koren; L A Magee
Journal: J Psychosom Obstet Gynaecol Date: 2000-09 Impact factor: 2.949

6. Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada.

Authors: P Mazzotta; C Maltepe; Y Navioz; L A Magee; G Koren
Journal: Int J Gynaecol Obstet Date: 2000-09 Impact factor: 3.561

7. Variables related to nausea and vomiting during pregnancy.

Authors: B O'Brien; Q Zhou
Journal: Birth Date: 1995-06 Impact factor: 3.689

7 in total

5 in total

Nausea and vomiting of pregnancy. Evidence-based treatment algorithm.

1. Therapeutic abortions due to severe morning sickness. Unacceptable combination.

Review 2. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

3. A prospective study of nausea and vomiting during pregnancy.

4. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.

5. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy.

6. Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada.

7. Variables related to nausea and vomiting during pregnancy.

1. Motherisk and Canadian Family Physician.

2.

3. Correction.

Review 4. Treatment of nausea and vomiting in pregnancy: an updated algorithm.

5. Feeding jejunostomy for the treatment of severe hyperemesis gravidarum: a case series.